Pregnancy History and Sex of Red Cell Donors Does Not Increase Mortality Risk for...
Previous research has suggested that receipt of a red blood cell (RBC) transfusion from a female donor who has ever been pregnant increases mortality...
Voxelotor Increases Hemoglobin, Decreases Hemolysis in Patients With Sickle Cell Disease
A report from the phase III HOPE trial found that once-daily voxelotor led to greater increases in hemoglobin (Hb) levels and larger reductions in...
Can a Patient’s Breath Detect Post-Transplant Gastrointestinal Graft-Versus-Host Disease?
Analyzing the volatile organic compounds (VOCs) expelled in the breath can help clinicians detect and monitor gastrointestinal graft-versus-host disease (GI GVHD) in patients who...
Bluebird Bio Wins European Approval for Beta Thalassemia Gene Therapy
Bluebird Bio’s one-time gene therapy, Zynteglo, has been cleared by E.U. regulators for the treatment of beta thalassemia in patients aged 12 and older....
Short, Aggressive Antibiotic Therapy Inhibits Lymphocyte Proliferation in CTCL
According to a study published in Blood, patients with advanced-stage cutaneous T cell lymphoma (CTCL) a short, yet aggressive, antibiotic regimen inhibited disease activity...
Opioid Manufacturer Insys Therapeutics Files for Bankruptcy
Insys Therapeutics filed for Chapter 11 bankruptcy protection on June 10, just days after reaching a $225 million settlement with the U.S. Department of...
Evaluating Risk of Developing Second Cancers in Patients With Ph-Negative Myeloproliferative Neoplasms
According to results from a nested case-control study, patients with Philadelphia chromosome (Ph)–negative myeloproliferative neoplasms (MPNs) are at an increased risk of developing secondary...
ASH Backs Palliative Blood Transfusions During Hospice Care, Announces 2019 Honorific and Mentor Award...
ASH Backs the Use of Palliative Blood Transfusions During Hospice Care for Symptom Improvement
The American Society of Hematology (ASH) has announced its support...
FDA Launches Call Center for Compassionate-Use Requests
The FDA has launched a call center to field doctors’ requests for access to experimental cancer drugs for individual patients who have run out...
Polatuzumab Vedotin-piiq Receives FDA Approval for DLBCL
The FDA has approved the CD79b-directed antibody drug conjugate polatuzumab vedotin-piiq, in combination with bendamustine and rituximab (BR), to treat adults with relapsed or...
Current Issue
August 2019, Volume 5, Issue 10
This issue features a debate about gun control as a health care issue, a look at blood services in Israel and Palestine, and more.
